ListarEditados por otras instituciones por tema "Hypoglycemic Agents/adverse effects/therapeutic use"

Mostrando ítems 1-2 de 2

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Li, Ling; Li, Sheyu; Deng, Ke; Liu, Jiali; Vandvik, Per-Olav; Zhao, Pujing; Zhang, Longhao; Shen, Jiantong; Bala, Malgorzata-M.; Sohani, Zahra-N.; Wong, Evelyn; Busse, Jason-W.; Ebrahim, Shanil; Málaga Rodríguez, Germán Javier; Rios, Lorena-P.; Wang, Yingqiang; Chen, Qunfei; Guyatt, Gordon-H.; Sun, Xin (BMJ Publishing Group, 2016)

OBJECTIVES: To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. DESIGN: Systematic review ...
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies

Li, Ling; Li, Sheyu; Liu, Jiali; Deng, Ke; Busse, Jason-W.; Vandvik, Per-Olav; Wong, Evelyn; Sohani, Zahra-N.; Bala, Malgorzata-M.; Rios, Lorena-P.; Málaga Rodríguez, Germán Javier; Ebrahim, Shanil; Shen, Jiantong; Zhang, Longhao; Zhao, Pujing; Chen, Qunfei; Wang, Yingqiang; Guyatt, Gordon-H.; Sun, Xin (BioMed Central, 2016)

BACKGROUND: The effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or ...

Buscar en el Repositorio